← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

▼ SELL

$ Value

$39K

Shares

1,780

Price

$22

Filed

Jan 15

Insider

Name

DeLong Mark Jeffrey

Title

Chief Business & Strat Officer

CIK

0001856078

Roles

Officer

Transaction Details

Transaction Date

2026-01-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

83,058

Footnotes

This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 12, 2026. | This includes 893 shares from April 30, 2025 ESPP purchase.

Filing Info

Accession No.

0001492422-26-000030

Form Type

4

Issuer CIK

0001492422

DeLong Mark Jeffrey's History

Date Ticker Type Value
2026-02-11 APLS $8K
2026-01-28 APLS A $0
2026-01-22 APLS $73K
2026-01-20 APLS $26K
2026-01-13 APLS $39K
2025-06-09 APLS A $1.6M

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28